A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice

Citation
G. Kassiotis et al., A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice, EUR J IMMUN, 29(3), 1999, pp. 912-917
Citations number
18
Categorie Soggetti
Immunology
Journal title
EUROPEAN JOURNAL OF IMMUNOLOGY
ISSN journal
00142980 → ACNP
Volume
29
Issue
3
Year of publication
1999
Pages
912 - 917
Database
ISI
SICI code
0014-2980(199903)29:3<912:ATNFMO>2.0.ZU;2-J
Abstract
We have reported previously that in the central nervous system (CNS) local expression of tumor necrosis factor (TNF) transgenes can trigger the develo pment of oligodendrocyte apoptosis, primary inflammatory demyelination and neurological dysfunction, accompanied by lymphocyte and macrophage infiltra tion into the CNS. To distinguish between the local effects of transgene-en coded TNF and the potential encephalitogenic effects of immune infiltrates upon CNS disease pathogenesis, we have backcrossed Tg6074 TNF-transgenic mi ce to mice deficient in CD4, beta 2-microglobulin (beta 2m), immunoglobulin mu chain (Ig mu) or recombination activation gene-1 (Rag-1). TNF was capab le of triggering undiminished primary demyelination in all of the immunodef icient mice, in the presence of activated cells of the macrophage/microglia l lineage. We conclude that TNF is sufficient to induce primary inflammator y demyelination and neurological deficits even in the absence of adaptive i mmunity.